To include your compound in the COVID-19 Resource Center, submit it here.

Xolair omalizumab regulatory update

FDA approved an sBLA from Roche’s Genentech unit for Xolair

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE